Allergy and Immunology

  1. Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age

    1. Amelie E. Murrell
    2. Ewono Eyoh
    3. Jeffrey G. Shaffer
    4. Monika L. Dietrich
    5. Ivy V. Trinh
    6. Thomas J. Yockachonis
    7. Shuangyi Bai
    8. Crystal Y. Zheng
    9. Celia V. Mayne
    10. Sofia E. Cabrera
    11. Anyssa Aviles-Amaro
    12. Addison E. Stone
    13. Saraswatie Rambaran
    14. Sruti Chandra
    15. Debra H. Elliott
    16. Ashley R. Smira
    17. Sara N. Harris
    18. Katharine E. Olson
    19. Samantha J. Bilton
    20. Medea J. Gabriel
    21. Nicole D. Falgout
    22. Emily J. Engel
    23. Alisha D. Prystowsky
    24. Bo Ning
    25. Tony Hu
    26. Jay K. Kolls
    27. Samuel J. Landry
    28. Stacy S. Drury
    29. John S. Schieffelin
    30. Kevin J. Zwezdaryk
    31. James E. Robinson
    32. Bronwyn M. Gunn
    33. Elizabeth B. Norton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: application to SARS-Cov-2 vaccinated individuals

    1. Tiziana Altosole
    2. Gianluca Rotta
    3. Scott J. Bornheimer
    4. Daniela Fenoglio

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Clonal diversity determines persistence of SARS-CoV-2 epitope-specific T cell response

    1. Ksenia V. Zornikova
    2. Alexandra Khmelevskaya
    3. Savely A. Sheetikov
    4. Dmitry O. Kiryukhin
    5. Olga V. Shcherbakova
    6. Aleksei Titov
    7. Ivan V. Zvyagin
    8. Grigory A. Efimov

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

    1. Juan Manuel Carreño
    2. Gagandeep Singh
    3. Johnstone Tcheou
    4. Komal Srivastava
    5. Charles Gleason
    6. Hiromi Muramatsu
    7. Parnavi Desai
    8. Judith A. Aberg
    9. Rachel L. Miller
    10. PARIS study group
    11. Norbert Pardi
    12. Viviana Simon
    13. Florian Krammer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV

    1. Clara Bessen
    2. Carlos Plaza-Sirvent
    3. Agit Simsek
    4. Jaydeep Bhat
    5. Corinna Marheinecke
    6. Doris Urlaub
    7. Petra Bonowitz
    8. Sandra Busse
    9. Sabrina Schumann
    10. Elena Vidal Blanco
    11. Adriane Skaletz-Rorowski
    12. Norbert H. Brockmeyer
    13. Oliver Overheu
    14. Anke Reinacher-Schick
    15. Simon Faissner
    16. Carsten Watzl
    17. Stephanie Pfaender
    18. Anja Potthoff
    19. Ingo Schmitz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody

    1. Jing Jing Wang
    2. Bridie Armour
    3. Tim Chataway
    4. Alexander Troelnikov
    5. Alex Colella
    6. Olivia Yacoub
    7. Simon Hockley
    8. Chee Wee Tan
    9. Tom Paul Gordon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination

    1. Simon Ronicke
    2. Bilgin Osmanodja
    3. Klemens Budde
    4. Annika Jens
    5. Charlotte Hammett
    6. Nadine Koch
    7. Bianca Zukunft
    8. Friederike Bachmann
    9. Mira Choi
    10. Ulrike Weber
    11. Bettina Eberspächer
    12. Jörg Hofmann
    13. Fritz Grunow
    14. Michael Mikhailov
    15. Fabian Halleck
    16. Eva Schrezenmeier

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study

    1. Ekaterina A. Bryushkova
    2. Valeria D. Skatova
    3. Zinaida Y. Mutovina
    4. Alena I. Zagrebneva
    5. Daria S. Fomina
    6. Tatyana S. Kruglova
    7. Anna A. Akopyan
    8. Irina D. Strazhesko
    9. Sergey A. Lukyanov
    10. Olga N. Tkacheva
    11. Maryana A. Lysenko
    12. Dmitry M. Chudakov

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Interpretation of non-responders to SARS-CoV-2 vaccines using WHO International Standard

    1. Qiang Zeng
    2. Xue Yang
    3. Qi Gao
    4. Biao-yang Lin
    5. Yong-zhe Li
    6. Gang Huang
    7. Yang Xu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19

    1. Ronja Mothes
    2. Anna Pascual-Reguant
    3. Ralf Koehler
    4. Juliane Liebeskind
    5. Alina Liebheit
    6. Sandy Bauherr
    7. Lars Philipsen
    8. Carsten Dittmayer
    9. Michael Laue
    10. Regina von Manitius
    11. Sefer Elezkurtaj
    12. Pawel Durek
    13. Frederik Heinrich
    14. Gitta A. Heinz
    15. Gabriela M. Guerra
    16. Benedikt Obermayer
    17. Jenny Meinhardt
    18. Jana Ihlow
    19. Josefine Radke
    20. Frank L. Heppner
    21. Philipp Enghard
    22. Helena Stockmann
    23. Tom Aschman
    24. Julia Schneider
    25. Victor M. Corman
    26. Leif E. Sander
    27. Mir-Farzin Mashreghi
    28. Thomas Conrad
    29. Andreas C. Hocke
    30. Raluca A. Niesner
    31. Helena Radbruch
    32. Anja E. Hauser

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 5 of 24 Next